Serratì, Simona
Di Fonte, Roberta
Porcelli, Letizia
De Summa, Simona
De Risi, Ivana
Fucci, Livia
Ruggieri, Eustachio
Marvulli, Tommaso Maria
Strippoli, Sabino
Fasano, Rossella
Rafaschieri, Tania
Guida, Gabriella
Guida, Michele
Azzariti, Amalia
Funding for this research was provided by:
Regione Puglia (Tecnopolo per la Medicina di Precisione (CUP B84I18000540002))
Ministero della Salute (RC 2022-2024: Identificazione di fattori circolanti per la diagnosi, prognosi e/o predizione della risposta alle terapie in patologie tumorali solide)
Alleanza Contro il Cancro (Medicina personalizzata: Allestimento di biobanche e di modelli colturali organotipici da pazienti con melanoma per l’identificazione di nuovi marcatori prognostici e la realizzazione di saggi predittivi della risposta del paziente alla terapia, ACC Preclinical research platform for precision oncology-cod WFR: RCR-2022-23682287)
Article History
Received: 16 June 2023
Accepted: 22 August 2023
First Online: 28 September 2023
Declarations
:
: The study was previously approved by the ethics committee of the IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy, (Prot. 590/16 C.E.) and written informed consent was obtained from all the patients enrolled in the study. The study for in vitro/ex vivo MM model preparation was previously approved by the Ethics Committee of the IRCCS Istituto Tumori Giovanni Paolo II (Prot. 737/CE) and written informed consent was obtained from all the patients enrolled in the study.
: Not applicable.
: The authors declare that they have no competing interests.